MindImmune Therapeutics, Inc.
Pharmaceutical company · Kingston, Rhode Island, United States
MindImmune Therapeutics, Inc. is a pharmaceutical company headquartered in Kingston, Rhode Island, United States. Its earliest recorded incorporation is in 2016. It has reported private securities offerings to the US SEC, most recently $15 million sold in a notice filed in 2026.
MindImmune Therapeutics at a glance
What does MindImmune Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $15.2 million sold (2026).
Frequently asked questions about MindImmune Therapeutics
Where is MindImmune Therapeutics headquartered?
MindImmune Therapeutics, Inc. is headquartered in Kingston, Rhode Island, United States.
What does MindImmune Therapeutics do?
MindImmune Therapeutics, Inc. is a pharmaceutical company.
When was MindImmune Therapeutics founded?
The earliest incorporation on record for MindImmune Therapeutics, Inc. is in 2016, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences